Evaluation of transduction efficiency in pancreatic beta and alpha cells utilizing various AAV serotypes
Open Access
- 1 July 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Abstract
Adeno-associated viruses (AAVs) have emerged as powerful tools for delivering genes to various cell types, including pancreatic endocrine cells. Currently, AAV serotype 8 (AAV8) is the primary AAV vector employed for transducing pancreatic cells for transgene expression. We aimed to determine whether alternative serotypes, specifically AAV2, AAV6, and AAV9, commonly used for gene transfer, can efficiently transduce pancreatic cells in vitro. Murine pancreatic β-cells, α-cells, and fibroblasts were transduced with AAV serotypes 2, 6, and 9 carrying the transgene for enhanced green fluorescent protein (eGFP). To understand further the interaction between the foregoing AAV types and the cells for optimal transduction, the additives heparin and neuraminidase were screened. AAV2 outperformed AAV9 in transducing pancreatic cells, while AAV6 induced cytotoxicity. Recombinant AAV2 was also utilized to deliver a blue-light photoactivatable adenylyl cyclase (bPAC) to β-cells, resulting in the efficient modulation of insulin secretion upon illumination. Both AAV2 and AAV9 displayed slightly higher tropism for α-cells than for β-cells, potentially mirroring differences in the expression of heparan sulfate proteoglycan (HSPG)-processing enzymes. The fraction of GFP-expressing cells at various multiplicities of infection was consistently lower for fibroblasts than for the pancreatic cells. Incubation of AAV2 with heparin before transduction failed to induce transgene expression in β-cells, indicating that HSPGs are the primary interaction sites with pancreatic cells. Treating β-cells with neuraminidase before exposure to AAV9 did not significantly improve the transduction efficiency. These findings expand the repertoire of available serotypes for AAV-mediated delivery of transgenes to pancreatic endocrine cells in vitro and may contribute to designing efficacious gene therapy strategies for pancreas pathologies.Keywords
Funding Information
- National Science Foundation (CBET-1951104)
This publication has 59 references indexed in Scilit:
- Lentiviral Vectors and Adeno‐Associated Virus Vectors: Useful Tools for Gene Transfer in Pain ResearchThe Anatomical Record, 2018
- Synthetic heparin and heparan sulfate: probes in defining biological functionsCurrent Opinion in Chemical Biology, 2017
- Adeno-Associated Virus (AAV) as a Vector for Gene TherapyBioDrugs, 2017
- Cellular transduction mechanisms of adeno-associated viral vectorsCurrent Opinion in Virology, 2016
- Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell lineHistochemistry and Cell Biology, 2012
- Adeno-Associated Virus 2 Infection Requires Endocytosis through the CLIC/GEEC PathwayCell Host & Microbe, 2011
- In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9Diabetologia, 2011
- Adenoviral vector‐mediated glucagon‐like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty ratsThe Journal of Gene Medicine, 2008
- Calcium Phosphate TransfectionCurrent Protocols in Cell Biology, 2003
- Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolutionAmerican Journal of Physical Anthropology, 2001